Fresenius reported €2.52B in Gross Profit on Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Akzo Nobel AKZA:NA 927M 107M
Alcon AG ALC:SW 1.19B 26M
AstraZeneca AZN:LN 6.04B 15M
BASF BAS:GR 4.91B 174M
Bayer BAYN:GR 5.89B 414M
Davita Healthcare Partners DVA:US $ 929.73M 21.5M
E.ON EOAN:GR -6513000000 8.57B
Fresenius FRE:GR € 2523M 95M
Fresenius Medical Care FME:GR € 1267M 16.99M
Fresenius Medical Care FMS:US $ 1267M 16.99M
Getinge GETIB:SS 3.13B 294M
Givaudan GIVN:VX 1.48B 180M
GlaxoSmithKline GSK:LN 6.26B 682M
GN Store Nord GN:DC 2.11B 17M
GRIFOLS GRF:SM € 580.8M 47.47M
Hikma Pharmaceutical HIK:LN 616M 5M
Lonza Group LONN:SW 1.04B 418M
Merck MRK:GR € 3114M 57M
Novartis NOVN:VX 9.52B 21M
Philips PHIA:NA € 1974M 185M
RWE RWE:GR € 896M 77M
William Demant Holding WDH:DC 6.72B 633M